A rat colon cancer model induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, PhIP

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 506-507, Issue , 2002, Pages 137-144

  Nakagama, Hitoshi ^a   Ochiai, Masako ^a   Ubagai, Tsuneyuki ^a   Tajima, Rie ^a   Fujiwara, Kyoko ^a   Sugimura, Takashi ^a   Nagao, Minako ^b  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

Author keywords

Colon carcinogenesis; Dysplastic ACF; PhIP; Rat; Susceptibility

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SUSCEPTIBILITY; COLON CARCINOGENESIS; COLON CARCINOMA; CONTROLLED STUDY; GENE MUTATION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HEREDITY; HISTOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CARCINOGENS; CHROMOSOMES; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMIDAZOLES; RATS; RATS, INBRED ACI; RATS, INBRED F344;

EID: 0037201538     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(02)00160-4     Document Type: Article

References (35)

1. J.S. Felton, M. Jägerstad, M.G. Knize, K. Skog, K. Wakabayashi, Contents in foods, beverages and tobacco, in: M. Nagao, T. Sugimura (Eds.), Food Borne Carcinogens, Wiley, Chichester, 2000, pp. 31-71.
2. Takahashi S., Ogawa K., Ohshima H., Esumi H., Ito N., Sugimura T. Induction of aberrant crypt foci in the large intestine of F344 rats by oral administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn. J. Cancer Res. 82:1991;135-137.
3. Bird R.P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 37:1987;147-151.
4. Ito N., Hasegawa R., Sano M., Tamano S., Esumi H., Takayama S., Sugimura T. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis. 12:1991;1503-1506.
5. Hasegawa R., Sano M., Tamano S., Imaida K., Shirai T., Nagao M., Sugimura T., Ito N. Dose-dependence of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) carcinogenicity in rats. Carcinogenesis. 14:1993;2553-2557.
6. Kakiuchi H., Watanabe M., Ushijima T., Toyota M., Imai K., Weiburger J.H., Sugimura T., Nagao M. Specific 5′-GGGA-3′ to 5′-GGA-3′ mutation of the Apc gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Proc. Natl. Acad. Sci. U.S.A. 92:1999;910-914.
7. Ubagai T., Ochiai M., Kawamori T., Imai H., Sugimura T., Nagao M., Nakagama H. Efficient induction of rat large intestinal tumors with a new spectrum of mutations by intermittent administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in combination with a high fat diet. Carcinogenesis. 23:2002;197-200.
8. Kinzler K.W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 87:1996;159-170.
9. Polakis P. Wnt signaling and cancer. Genes Dev. 14:2000;1837-1851.
10. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., Kinzler K.W. Identification of c-myc as a target of the APC pathway. Science. 281:1998;1509-1512.
11. Tetsu O., McCormick F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 398:1999;422-426.
12. He T.C., Chan T.A., Vogelstein B., Kinzler K.W. PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell. 99:1999;335-345.
13. Crawford H.C., Fingleton B.M., Rudolph-Owen L.A., Goss K.J., Rubinfeld B., Polakis P., Matrisian L.M. The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors. Oncogene. 18:1999;2883-2891.
14. Takahashi M., Fukuda K., Sugimura T., Wakabayashi K. β-Catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res. 58:1998;42-46.
15. Dashwood R.H., Suzui M., Nakagama H., Sugimura T., Nagao M. High frequency of β-catenin (Ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat. Cancer Res. 58:1998;1127-1129.
16. Esteller M., Corn P.G., Baylin S.B., Herman J.G. A gene hypermethylation profile of human cancer. Cancer Res. 61:2001;3225-3229.
17. Pretlow T.P., Barrow B.J., Ashton W.S., O'Riordan M.A., Pretlow T.G., Jurcisek J.A., Stellato T.A. Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res. 51:1991;1564-1567.
18. Jen J., Powell S.M., Papadopoulos N., Smith K.J., Hamilton S.R., Vogelstein B., Kinzler K.W. Molecular determinants of dysplasia in colorectal lesions. Cancer Res. 54:1994;5523-5526.
19. Smith A.J., Stern H.S., Penner M., Hay K., Mitri A., Bapat B.V., Gallinger S. Somatic Apc and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res. 54:1994;5527-5530.
20. Takayama T., Katsuki S., Takahashi Y., Ohi M., Nojiri S., Sakamaki S., Kato J., Kogawa K., Miyake H., Niitsu Y. Aberrant crypt foci of the colon as precursors of adenoma and cancer. New Engl. J. Med. 339:1998;1277-1284.
21. McLellan E.A., Bird R.P. Aberrant crypts: potential preneoplastic lesions in the murine colon. Cancer Res. 48:1988;6187-6192.
22. Tudek B., Bird R.P., Bruce W.R. Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods. Cancer Res. 49:1989;1236-1240.
23. 2-(2′-deoxyguanosin-8-yl)-PhIP. Carcinogenesis. 13:1992;629-635.
24. Ochiai M., Nakagama H., Watanabe M., Ishiguro Y., Sugimura T., Nagao M. Efficient method for rapid induction of aberrant crypt foci in rats with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn. J. Cancer Res. 87:1996;1029-1033.
25. Nakagama H., Souda K., Ochiai M., Ishiguro Y., Sugimura T., Nagao M. Genetic analysis of the susceptibility in rats to aberrant crypt foci formation by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, PhIP. Cancer Lett. 143:1999;205-209.
26. Watanabe T.K., Bihoreau M.-T., McCarthy L.C., Kiguwa S.L., Hishigaki H., Tsuji A., Browne J., Yamasaki U., Mizoguchi-Miyakita A., Oga K., Ono T., Okuno S., Kanemoto N., Takahashi E., Tomita K., Hayashi H., Adachi M., Webber C., Davis M., Kiel S., Knights C., Smith A., Critcher R., Miller J., Thangarajah T., Day P.J.R., Hudson J.R. Jr., Irie Y., Takagi T., Nakamura Y., Goodfellow P.N., Lathrop G.M., Tanigami A., James M.R. A radiation hybrid map of the rat genome containing 5,255 markers. Nat. Genet. 22:1999;27-36.
27. Yu C.E., Oshima J., Fu Y.H., Wijsman E.M., Hisama F., Alish R., Matthews S., Nakura J., Miki T., Quasis S., Martin G.M., Mulligan J., Schellenberg G.D. Positional cloning of the Werner's syndrome gene. Science. 272:1996;258-262.
28. Li B., Comai L. Functional interaction between Ku and the Werner syndrome protein in DNA end processing. J. Biol. Chem. 275:2000;28349-28352.
29. Ochiai M., Watanabe M., Kushida H., Wakabayashi K., Sugimura T., Nagao M. DNA adduct formation, cell proliferation and aberrant crypt focus formation induced by PhIP in male and female rat colon with relevance to carcinogenesis. Carcinogenesis. 17:1996;95-98.
30. Tsukamoto T., Tanaka H., Fukami H., Inoue M., Takahashi M., Wakabayashi K., Tatematsu M. More frequent β-catenin gene mutations in adenomas than in aberrant crypt foci or adenocarcinomas in the large intestines of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) treated rats. Jpn. J. Cancer Res. 91:2000;792-796.
31. Paulsen J.E., Namork E., Steffensen I.-L., Eide T.J., Alexander J. Identification and quantification of aberrant crypt foci in the colon of Min mice - a murine model of familial adenomatous polyposis. Scand. J. Gastroenterol. 35:2000;534-539.
32. Paulsen J.E., Steffensen I.-L., Loberg E.M., Husoy T., Namork E., Alexander J. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon. Cancer Res. 61:2001;5010-5015.
33. Pretlow T.P., O'Riordan M.A., Spancake K.M., Pretlow T.G. Two types of putative preneoplastic lesions identified by hexosaminidase activity in whole-mounts of colons from F344 rats treated with carcinogen. Am. J. Pathol. 142:1993;1695-1700.
34. Yamada Y., Yoshimi N., Hirose Y., Kawabata K., Matsunaga K., Shimizu M., Hara A., Mori H. Frequent β-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res. 60:2000;3323-3327.
35. Y. Yamada, N. Yoshimi, Y. Hirose, K. Matsunaga, M. Katayama, K. Sakata, M. Shimizu, T. Kuno, H. Mori, Sequential analysis of morphological and biological properties of β-catenin accumulated crypts, provable pre-malignant lesions independent of aberrant crypt foci in rat colon carcinogenesis, Cancer Res. 61 (2001) 1874-1878.